A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With DMARDs Versus DMARDs Alone in Patients With Rheumatoid Arthritis
Clinical trial NCT01787149 · UNKNOWN
Trial details
- NCT number
- NCT01787149
- Sponsor
- Mycenax Biotech Inc.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2017-12-01
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.